Georgetown [Guyana] : Guyana has recognised Bharat Biotech’s Covaxin COVID-19 vaccine, said High Commission of India in Georgetown, Guyana on Tuesday.
“#Guyana has recognized #India’s indigenous vaccine #COVAXIN-important step forward in the post-COVID partnership between India and Guyana,” the Indian Embassy tweeted. On Monday, Australian government gave recognition to Covaxin for the purpose of establishing a traveller’s vaccination status in the country.
The UN health body — World Health Organisation — has sought additional clarifications from Bharat Biotech, which manufactures Covaxin, and a decision on emergency use authorisation is expected soon.
Foreign Secretary Harsh Vardhan Shringla has said that the government is carefully following the discussions taking place within the health body and hoped that approval for the indigenous COVID-19 vaccine will be granted soon.
“WHO’s technical advisory group (TAG), which is a regulatory body, met Bharat Biotech officials on October 26. They had a few questions for Bharat Biotech. From what we understand, the company will submit its reply soon. According to me, once the regulatory group is satisfied with the response, the approval for Covaxin should be given soon,” Shringla said.
Must Read
- Australia adds Covaxin to list of 'recognised' COVID-19…
- Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8%…
- Bharat Biotech awaits feedback from WHO for COVID-19 vaccine…
- Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy…
- WHO to decide on Bharat Biotech's Covaxin emergency usage in…
- Bharat Biotech's partner seeks Covaxin approval in US for…
- Covaxin found to be safe, immunogenic in 2-18 age group in…
- Covaxin-maker Bharat Biotech MD D Krishna Ella and Suchitra…
- 96 countries recognised Covishield, Covaxin: Health Minister…
- Bharat Biotech gets SEC approval for phase 3 clinical trials…